171 related articles for article (PubMed ID: 9669251)
1. Value of pharmacologic stress echocardiography in risk stratification of patients with single-vessel disease: a report from the Echo-Persantine and Echo-Dobutamine International Cooperative Studies.
Cortigiani L; Picano E; Landi P; Previtali M; Pirelli S; Bellotti P; Bigi R; Magaia O; Galati A; Nannini E
J Am Coll Cardiol; 1998 Jul; 32(1):69-74. PubMed ID: 9669251
[TBL] [Abstract][Full Text] [Related]
2. Ultra-early risk stratification after myocardial infarction via pharmacological stress echocardiography: the relative value of resting function, viability and myocardial ischemia.
Sclavo M; Aruta E; Presbitero P
G Ital Cardiol; 1997 Oct; 27(10):1000-7. PubMed ID: 9359049
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: a prospective, large-scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test. Echo-Persantine International Cooperative (EPIC) and Echo-Dobutamine International Cooperative (EDIC) Study Groups.
Pingitore A; Picano E; Varga A; Gigli G; Cortigiani L; Previtali M; Minardi G; Colosso MQ; Lowenstein J; Mathias W; Landi P
J Am Coll Cardiol; 1999 Nov; 34(6):1769-77. PubMed ID: 10577568
[TBL] [Abstract][Full Text] [Related]
4. Risk stratification by pharmacological stress echocardiography in a primary care cardiology centre. Experience in 1082 patients.
Cortigiani L; Lombardi M; Landi P; Paolini EA; Nannini E
Eur Heart J; 1998 Nov; 19(11):1673-80. PubMed ID: 9857920
[TBL] [Abstract][Full Text] [Related]
5. Dipyridamole stress echocardiography for risk stratification in hypertensive patients with chest pain.
Cortigiani L; Paolini EA; Nannini E
Circulation; 1998 Dec 22-29; 98(25):2855-9. PubMed ID: 9860787
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of pharmacological stress echocardiography in women with chest pain and unknown coronary artery disease.
Cortigiani L; Dodi C; Paolini EA; Bernardi D; Bruno G; Nannini E
J Am Coll Cardiol; 1998 Dec; 32(7):1975-81. PubMed ID: 9857881
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic stress echocardiography in the assessment of coronary artery disease.
Picano E; Trivieri MG
Curr Opin Cardiol; 1999 Nov; 14(6):464-70. PubMed ID: 10579061
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic value of dipyridamole echocardiography in patients with suspected coronary artery disease. Comparison with exercise electrocardiography.
Severi S; Picano E; Michelassi C; Lattanzi F; Landi P; Distante A; L'Abbate A
Circulation; 1994 Mar; 89(3):1160-73. PubMed ID: 8124803
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of dipyridamole echocardiography early after myocardial infarction in elderly patients. Echo Persantine Italian Cooperative (EPIC) Study Group.
Camerieri A; Picano E; Landi P; Michelassi C; Pingitore A; Minardi G; Gandolfo N; Seveso G; Chiarella F; Bolognese L
J Am Coll Cardiol; 1993 Dec; 22(7):1809-15. PubMed ID: 8245333
[TBL] [Abstract][Full Text] [Related]
10. Clinical, exercise electrocardiographic, and pharmacologic stress echocardiographic findings for risk stratification of hypertensive patients with chest pain.
Cortigiani L; Coletta C; Bigi R; Amici E; Desideri A; Odoguardi L
Am J Cardiol; 2003 Apr; 91(8):941-5. PubMed ID: 12686332
[TBL] [Abstract][Full Text] [Related]
11. Does stress echocardiography predict the site of future myocardial infarction? A large-scale multicenter study. EPIC (Echo Persantine International Cooperative) and EDIC (Echo Dobutamine International Cooperative) study groups.
Varga A; Picano E; Cortigiani L; Petix N; Margaria F; Magaia O; Heyman J; Bigi R; Mathias W; Gigli G; Landi P; Raciti M; Pingitore A; Sicari R
J Am Coll Cardiol; 1996 Jul; 28(1):45-51. PubMed ID: 8752793
[TBL] [Abstract][Full Text] [Related]
12. The atropine factor in pharmacologic stress echocardiography. Echo Persantine (EPIC) and Echo Dobutamine International Cooperative (EDIC) Study Groups.
Pingitore A; Picano E; Colosso MQ; Reisenhofer B; Gigli G; Lucarini AR; Petix N; Previtali M; Bigi R; Chiarandà G; Minardi G; de Alcantara M; Lowenstein J; Sclavo MG; Palmieri C; Galati A; Seveso G; Heyman J; Mathias W; Casazza F; Sicari R; Raciti M; Landi P; Marzilli M
J Am Coll Cardiol; 1996 Apr; 27(5):1164-70. PubMed ID: 8609337
[TBL] [Abstract][Full Text] [Related]
13. Safety, feasibility, and prognostic implications of pharmacologic stress echocardiography in 1482 patients evaluated in an ambulatory setting.
Cortigiani L; Picano E; Coletta C; Chiarella F; Mathias W; Gandolfo N; De Alcantara M; Mazzoni V; Gensini GF; Landi P; ;
Am Heart J; 2001 Apr; 141(4):621-9. PubMed ID: 11275930
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction. Echo Dobutamine International Cooperative (EDIC) Study.
Sicari R; Picano E; Landi P; Pingitore A; Bigi R; Coletta C; Heyman J; Casazza F; Previtali M; Mathias W; Dodi C; Minardi G; Lowenstein J; Garyfallidis X; Cortigiani L; Morales MA; Raciti M
J Am Coll Cardiol; 1997 Feb; 29(2):254-60. PubMed ID: 9014975
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: a dobutamine stress echocardiographic study.
Picano E; Sicari R; Landi P; Cortigiani L; Bigi R; Coletta C; Galati A; Heyman J; Mattioli R; Previtali M; Mathias W; Dodi C; Minardi G; Lowenstein J; Seveso G; Pingitore A; Salustri A; Raciti M
Circulation; 1998 Sep; 98(11):1078-84. PubMed ID: 9736594
[TBL] [Abstract][Full Text] [Related]
16. Dipyridamole-dobutamine echocardiography: a novel test for the detection of milder forms of coronary artery disease.
Ostojic M; Picano E; Beleslin B; Dordjevic-Dikic A; Distante A; Stepanovic J; Reisenhofer B; Babic R; Stojkovic S; Nedeljkovic M
J Am Coll Cardiol; 1994 Apr; 23(5):1115-22. PubMed ID: 8144777
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of high dose dipyridamole echocardiography in patients with chronic coronary artery disease and preserved left ventricular function.
Coletta C; Galati A; Greco G; Burattini M; Ricci R; Carunchio A; Fera MS; Bordi L; Ceci V
J Am Coll Cardiol; 1995 Oct; 26(4):887-94. PubMed ID: 7560613
[TBL] [Abstract][Full Text] [Related]
18. Integrated evaluation of relation between coronary lesion features and stress echocardiography results: the importance of coronary lesion morphology.
Beleslin BD; Ostojic M; Djordjevic-Dikic A; Babic R; Nedeljkovic M; Stankovic G; Stojkovic S; Marinkovic J; Nedeljkovic I; Stepanovic J; Saponjski J; Petrasinovic Z; Nedeljkovic S; Kanjuh V
J Am Coll Cardiol; 1999 Mar; 33(3):717-26. PubMed ID: 10080473
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the prognostic value of dipyridamole and dobutamine stress echocardiography in patients with known or suspected coronary artery disease.
Schröder K; Wieckhorst A; Völler H
Am J Cardiol; 1997 Jun; 79(11):1516-8. PubMed ID: 9185644
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of dipyridamole or dobutamine stress echocardiography for evaluation of patients > or =65 years of age with known or suspected coronary heart disease.
Cortigiani L; Bigi R; Sicari R; Landi P; Bovenzi F; Picano E
Am J Cardiol; 2007 Jun; 99(11):1491-5. PubMed ID: 17531567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
